4 unknown. 4 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Unknown 4 |
| Phase 1 | 1 | Unknown 1 |
Follow ribociclib: new trials by email Literature Review of ribociclib trials Research Report on ribociclib
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Randomized Study Comparing the Immune Modulation Effect of Ribociclib, Palbociclib, and Abemaciclib in ER+/HER2- EBC Palbociclib, Ribociclib, Abemaciclib - Breast Cancer, Hormone Receptor-positive Breast Cancer | Phase 2 | Unknown | National Taiwan University Hospital | 60 | 2022-09-16 | 2023-03-16 |
| Phase IB & II Study of Ribociclib With Trastuzumab Plus Letrozole in Postmenopausal HR+, HER2+ Advanced Breast Cancer Patients Ribociclib, Trastuzumab, Letrozole - HER2-positive Breast Cancer, Postmenopausal | Phase 1 / Phase 2 | Unknown | Yonsei University | 95 | 2019-06-10 | 2022-05-10 |
| A Study Assessing Efficacy & Safety of Ribociclib in Patients With Advanced Well/Dedifferentiated Liposarcoma Ribociclib - Liposarcomas, Dedifferentiated, Liposarcoma - Well Differentiated | Phase 2 | Unknown | Assaf-Harofeh Medical Center | 30 | 2016-07-01 | 2017-10-25 |
| A Phase II Study Assessing Efficacy & Safety of Ribociclib in Patients With Advanced Well/Dedifferentiated Liposarcoma ribociclib - Liposarcoma, Soft Tissue Sarcoma | Phase 2 | Unknown | Hadassah Medical Organization | 30 | 2016-05-01 | 2016-11-23 |
Breast Neoplasms (2) · Liposarcoma (2) · Sarcoma (2) · Lipoma (1) · Liposarcoma, Myxoid (1)
Assaf-Harofeh Medical Center (1) · Hadassah Medical Organization (1) · National Taiwan University Hospital (1) · Yonsei University (1)
Israel (2) · South Korea (1) · Taiwan (1)
Daniela Katz, M.D (1) · Daniela Katz, MD (1) · Yen-Shen Lu, MD, PhD (1)